Zhang Y, Zeng G, Pan H, Li C, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 2020 Nov 17. pii: S1473-3099(20)30843.
PMID: 33217362